New Key Statistics Module, Z-Score and F-Score
AMEX:LCTX Key Ratios
Market Cap $ M | 205.79 |
Enterprise Value $ M | 155.98 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.87 |
Price/Sales | 23.70 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 8.00 |
EPS (TTM) $ | -0.13 |
Beneish M-Score | -3.22 |
10-y EBITDA Growth Rate % | 16.30 |
5-y EBITDA Growth Rate % | 13.80 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -6.30 |
EV-to-EBITDA | -6.48 |
PEG | -- |
Shares Outstanding M | 188.80 |
Net Margin (%) | -295.59 |
Operating Margin % | -309.28 |
Pre-tax Margin (%) | -295.30 |
Quick Ratio | 2.71 |
Current Ratio | 2.71 |
ROA % (ttm) | -21.88 |
ROE % (ttm) | -34.08 |
ROIC % (ttm) | -32.27 |
Dividend Yield % | -- |
Altman Z-Score | -2.24 |
LCTX Number of Guru Trades
LCTX Volume of Guru Trades
Gurus Latest Trades with AMEX:LCTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:LCTX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Lineage Cell Therapeutics Inc Insider Transactions
No Available Data
News about AMEX:LCTX
Total 0- 1